Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of two traditional Chinese medicinal ingredients—honeysuckle (Lonicera japonica) and semen oroxyli (Oroxylum indicum seeds)—used primarily as a gargle solution. The combination has demonstrated anti-inflammatory, antioxidant, analgesic, and antibacterial properties. Clinical studies have shown that a gargle containing honeysuckle and semen oroxyli can relieve both resting and swallowing throat pain after uvulopalatopharyngoplasty (UPPP), likely due to the inhibition of inflammatory mediators such as cyclooxygenase-2 (COX-2) and interleukin-6 (IL-6). Honeysuckle is known for its anti-inflammatory effects via the NF-κB pathway, while semen oroxyli also exhibits significant anti-inflammatory and analgesic activities. Both components contribute to reducing inflammation-induced pain in postoperative settings[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on honeysuckle + semen oroxyli.